AIM
IBB icon

Axiom Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Axiom Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.1K Buy
+400
New +$68.8K 0.05% 179
2022
Q1 		– Sell
-500
Closed -$76K – 121
2021
Q4 		$76K Buy
+500
New +$77.4K 0.07% 121
2019
Q2 		– Sell
-150
Closed -$17K – 467
2019
Q1 		$17K Buy
+150
New +$16.5K ﹤0.01% 411

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Axiom Investment Management's IBB Position: Q2 2026 in Review

Axiom Investment Management opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 400 shares worth $76.1K. The stake represents 0.05% of the portfolio and ranks #179 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in IBB as recently as Q4 2021.

Axiom Investment Management first reported a position in IBB in Q1 2019 and has held it in 3 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Axiom Investment Management held 400 shares of iShares Biotechnology ETF worth $76.1K as of Q2 2026.
  • iShares Biotechnology ETF was a new Axiom Investment Management position in Q2 2026.
  • iShares Biotechnology ETF made up 0.05% of Axiom Investment Management's portfolio in Q2 2026, its #179 holding.
  • Axiom Investment Management first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 3 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.